Jessica Shiu, MD, PhD
Multimodal Analyses of Stable Vitiligo Skin Identify Tissue Interactions That Control Disease Persistence
Entries by Patrick Dockins
Poster Session Q&A #3
Laila Benzekri, MD
Avina Jain, MBBS, MD
Reenu T. George, MD
Prakhar Srivastava, MBBS, MD
Samia Esmat, MD
Vitiligo Treatment: Patient’s or Doctor’s Decision ?!!
Rania Mogawer, MD
Efficacy of Narrow Band UVB With or Without Oral Mini-Pulse Steroids in Stabilization of Vitiligo Activity in Skin Phototypes (III -V): A Double Blind Randomized Placebo Controlled Prospective Multi-Center Study
Marissa Ceresnie, DO
Investigating Disparities in Recording Race and Ethnicity in Vitiligo Clinical Trial Screening Assessments
Monica Ottaviani, PhD
Vitiligo: The Skin Barrier Point of View
Jayvadan Vaishnav, MSc
Involvement of VTCN1 and Its Cleaving Enzyme NRD1 in Vitiligo Pathogenesis
Ahmed Mourad, MBBS, MS
Assessment of Tissue PD-1 and PD-l1 Levels in Vitiligo Patients (Case Control Study)
Poster Session Q&A #4
Sanjay Kumar Kanodia, MD
Paras Choudhary, MD
Nicoline Post, MD
Alexandria Brown, BSA
Thierry Passeron, MD, PhD
Invited Speaker:
Oral Gliadin-Protected Superoxide Dismutase in Addition to Phototherapy for Treating Non-segmental Vitiligo: A 24-Week Prospective Randomized Placebo-Controlled Study